Lazard Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.78M | Sell |
|
|||||
|
2025
Q2 | $2.88M | Sell |
|
|||||
|
2025
Q1 | $2.17M | Sell |
|
|||||
|
2024
Q4 | $2.79M | Sell |
|
|||||
|
2024
Q3 | $4M | Buy |
|
|||||
|
2024
Q2 | $4.01M | Sell |
|
|||||
|
2024
Q1 | $5.87M | Sell |
|
|||||
|
2023
Q4 | $6.08M | Sell |
|
|||||
|
2023
Q3 | $5.24M | Sell |
|
|||||
|
2023
Q2 | $6.67M | Sell |
|
|||||
|
2023
Q1 | $5.6M | Buy |
|
|||||
|
2022
Q4 | $4.97M | Sell |
|
|||||
|
2022
Q3 | $14.8M | Sell |
|
|||||
|
2022
Q2 | $16.1M | Buy |
|
|||||
|
2022
Q1 | $10.9M | Buy |
|
|||||
|
2021
Q4 | $9.91M | Buy |
|
|||||
|
2021
Q3 | $6.52M | Buy |
|
|||||
|
2021
Q2 | $8.99M | Buy |
|
|||||
|
2021
Q1 | $94K | Sell |
|
|||||
|
2020
Q4 | $130K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $63K | Buy |
|